Gate News bot reported that according to Decrypt, Australian listed biotech company Opyl Limited announced the adoption of a Bitcoin financial strategy amid tight cash flow, purchasing approximately 2 Bitcoins (valued at about $214,500) through the ASX-listed DigitalX Bitcoin ETF. The company received a $1.3 million loan from non-executive director Tony Guoga (secured by Bitcoin, with an interest rate of 6.5%) in an attempt to alleviate the shortage of operating funds.
According to the data, Opyl had only $41,700 in cash left as of the end of March, with monthly operating expenses reaching $170,000. Tony Guoga emphasized that with the recognition of governments around the world, crypto assets are becoming “a validated forward-looking asset class.”
Disclaimer: The information on this page may come from third parties and does not represent the views or opinions of Gate. The content displayed on this page is for reference only and does not constitute any financial, investment, or legal advice. Gate does not guarantee the accuracy or completeness of the information and shall not be liable for any losses arising from the use of this information. Virtual asset investments carry high risks and are subject to significant price volatility. You may lose all of your invested principal. Please fully understand the relevant risks and make prudent decisions based on your own financial situation and risk tolerance. For details, please refer to
Disclaimer.
